Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Superinvestors holding VSTM, Q2 2026
No superinvestor reported holding VSTM in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of VSTM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q3 2023
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+30.2%)
Q2 2023
1 superinvestor holding at quarter end
Converted for a 1-for-12 split- Added
- Viking Global Investors (+145.4%)
Q2 2022
1 superinvestor holding at quarter end